abstract |
The present invention relates to an oral dosage form comprising N- (2-amino-4- (fluorobenzylamino) -phenyl) carbamic acid ethyl ester (retigabine) or a pharmaceutically acceptable salt or solvate thereof, The process of preparing such dosage forms and the use of such dosage forms in medicine. |